“It really is saving us a huge number of hours over the days, weeks and months. Having more relevant support at hand, not having to draft or review documents them from scratch - it all adds up.”
Southampton FCAccess all documents on Peer group analysis
In this issue: Research and development Pharmaceuticals—regulatory framework Advanced therapeutics Commercialisation Medical devices Advertising of medicines Intellectual property Daily and weekly news alerts New and updated content Trackers Useful information There will be no Weekly Highlights on 24 April 2025 Research and development Commission updates guidelines on responsible use of generative AI in research On 10 April 2025, the European Commission’s Directorate‑General for Research and Innovation released the second edition of its guidance on the responsible use of generative artificial intelligence (AI) in research. Targeted at researchers, research organisations and funders, the update complements the EU Artificial Intelligence Act (EU AI act). It details core principles—reliability, truthfulness, respect and accountability—for AI use. The guidance also calls for transparency about the AI tools employed, safeguards for sensitive data and intellectual property rights, and bans heavy reliance on AI in peer review. See: LNB News 10/04/2025 30...